Document:

Exhibit 10.1

    

    

    SUPPLEMENT NO. 1 (this “Supplement”) dated as of January 14, 2019 to the Amended and Restated Guarantee and Collateral Agreement dated as of October 31, 2018 (the “Guarantee and Collateral Agreement”), among SCIENCE APPLICATIONS INTERNATIONAL CORPORATION, a Delaware corporation (the “Borrower”), each Subsidiary of the Borrower from time to time party thereto (each such Subsidiary individually a “Guarantor” and collectively, the “Guarantors”; the Guarantors
        and the Borrower are referred to collectively herein as the “Grantors”) and CITIBANK, N.A. (together with its affiliates, “Citibank”), as collateral agent (in such capacity, the “Collateral Agent”) for the Secured Parties (as defined therein).

    

    

    A.  Reference is made to the Third Amended and Restated Credit Agreement dated as of October 31, 2018 (as amended,
        supplemented or otherwise modified from time to time, the “Credit Agreement”), among the Borrower, the lenders from time to
        time party thereto (the “Lenders”) and Citibank, as administrative agent for the Lenders and as Collateral Agent.

    

    

    B.  Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to such terms in the
        Credit Agreement or the Guarantee and Collateral Agreement referred to therein, as applicable.

    

    

    C.  The Grantors have entered into the Guarantee and Collateral Agreement in order to induce the Lenders to make Loans and
        the Issuing Banks to issue Letters of Credit.  Section 7.16 of the Guarantee and Collateral Agreement provides that additional Subsidiaries of the Borrower may become Guarantors and Grantors under the Guarantee and Collateral Agreement by execution
        and delivery of an instrument in the form of this Supplement. The undersigned Subsidiaries of the Borrower (collectively, the “New
          Subsidiaries” and, each a “New Subsidiary”) are executing this Supplement in accordance with the requirements of the
        Credit Agreement to become Guarantors and Grantors under the Guarantee and Collateral Agreement in order to induce the Lenders to make additional Loans and the Issuing Banks to issue additional Letters of Credit and as consideration for Loans
        previously made and Letters of Credit previously issued.

    

    

    Accordingly, the Collateral Agent and the New Subsidiaries agree as follows:

    

    

    SECTION 1.  In accordance with Section 7.16 of the Guarantee and Collateral Agreement, each New Subsidiary by its
        signature below becomes a Grantor and Guarantor under the Guarantee and Collateral Agreement with the same force and effect as if originally named therein as a Grantor and Guarantor and each New Subsidiary hereby (a) agrees to all the terms and
        provisions of the Guarantee and Collateral Agreement applicable to it as a Grantor and Guarantor thereunder and (b) represents and warrants that the representations and warranties made by it as a Grantor and Guarantor thereunder are true and
        correct on and as of the date hereof.  In furtherance of the foregoing, each New Subsidiary, as security for the payment and performance in full of the Obligations (as defined in the Credit Agreement), does hereby create and grant to the Collateral
        Agent, its successors and assigns, for the benefit of the Secured Parties, their successors and assigns, a security interest in and lien on all of such New Subsidiary’s right, title and interest in and to the Collateral (as defined in the Credit
        Agreement) of such New Subsidiary. Each reference to a “Grantor” or a “Guarantor” in the Guarantee and Collateral Agreement shall be deemed to include each New Subsidiary.  The Guarantee and Collateral Agreement is hereby incorporated herein by
        reference.

    
      
        

    

    SECTION 2.  Each New Subsidiary represents and warrants to the Collateral Agent and the other Secured Parties that this
        Supplement has been duly authorized, executed and delivered by it and constitutes its legal, valid and binding obligation, enforceable against it in accordance with its terms (subject to bankruptcy, insolvency, reorganization, moratorium or other
        laws relating to or generally affecting the rights of the Collateral Agent and/or the Secured Parties).

    

    

    SECTION 3.  This Supplement may be executed in counterparts (and by different parties hereto on different counterparts),
        each of which shall constitute an original, but all of which when taken together shall constitute a single contract. This Supplement shall become effective when the Collateral Agent shall have received counterparts of this Supplement that, when
        taken together, bear the signatures of each New Subsidiary and the Collateral Agent.  Delivery of an executed signature page to this Supplement by facsimile, “.pdf”, or other similar electronic format shall be as effective as delivery of a manually
        signed counterpart of this Supplement.

    

    

    SECTION 4.  Each New Subsidiary hereby represents and warrants that, as of the date hereof, (a) set forth on Schedule I
        attached hereto is a true and correct schedule of (i) any and all Equity Interests and Pledged Debt Securities now owned by such New Subsidiary and (ii) any and all Intellectual Property now owned by such New Subsidiary and (b) set forth under its
        signature hereto, is the true and correct legal name of such New Subsidiary and its jurisdiction of organization or formation.

    

    

    SECTION 5.  Except as expressly supplemented hereby, the Guarantee and Collateral Agreement shall remain in full force and
        effect.

    

    

    SECTION 6.  THIS SUPPLEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE
        STATE OF NEW YORK.

    

    

    SECTION 7.  In case any one or more of the provisions contained in this Supplement should be held invalid, illegal or
        unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein and in the Guarantee and Collateral Agreement shall not in any way be affected or impaired thereby (it being understood that the
        invalidity of a particular provision in a particular jurisdiction shall not in and of itself affect the validity of such provision in any other jurisdiction). The parties hereto shall endeavor in good-faith negotiations to replace the invalid,
        illegal or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provisions.

    
      
        

    

    SECTION 8.  All communications and notices hereunder shall (except as otherwise expressly permitted by the Guarantee and
        Collateral Agreement) be in writing and given as provided in Section 9.02 of the Credit Agreement. All communications and notices hereunder to each New Subsidiary shall be given to it in care of the Borrower as provided in Section 9.02 of the
        Credit Agreement.

    

    

    SECTION 9.  Each New Subsidiary agrees to reimburse the Collateral Agent for its out-of-pocket expenses in connection with
        this Supplement, including the fees, other charges and disbursements of counsel for the Collateral Agent, to the extent provided for in Section 9.04 of the Credit Agreement.

    
      
        

    

    IN WITNESS WHEREOF, each New Subsidiary and the Collateral Agent have duly executed this Supplement to the Guarantee and
        Collateral Agreement as of the day and year first above written.

    

    

    	 	
            ENGILITY HOLDINGS, INC.

          
	 	 
	 	
            by

          	 
	 	 	/s/ Charles A. Mathis
	 	 	
            Name: Charles A. Mathis

          
	 	 	
            Title: Chief Financial Officer

          
	 	 	
            Address: 12010 Sunset Hills Road, Reston VA 20190

          
	 	 	
            Legal Name: Engility Holdings, Inc.

          
	 	 	
            Jurisdiction of Formation: Delaware

          

    

    

    	 	
            ENGILITY CORPORATION

          
	 	 
	 	
            by

          	 
	 	 	/s/ Charles A. Mathis
	 	 	
            Name: Charles A. Mathis

          
	 	 	
            Title: Chief Financial Officer

          
	 	 	
            Address: 12010 Sunset Hills Road, Reston VA 20190

          
	 	 	
            Legal Name: Engility Corporation

          
	 	 	
            Jurisdiction of Formation: Massachusetts

          

    

    

    	 	
            ENGILITY LLC

          
	 	 
	 	
            by

          	 
	 	 	/s/ Charles A. Mathis
	 	 	
            Name: Charles A. Mathis

          
	 	 	
            Title: Chief Financial Officer

          
	 	 	
            Address: 12010 Sunset Hills Road, Reston VA 20190

          
	 	 	
            Legal Name: Engility LLC

          
	 	 	
            Jurisdiction of Formation: Delaware

          

    

    

    
      [Signature page to Supplement to Guarantee and Collateral Agreement]

    

    
      
        

    

    	 	
            ATAC SERVICES, LLC

          
	 	 
	 	
            by

          	 
	 	 	/s/ Charles A. Mathis
	 	 	
            Name: Charles A. Mathis

          
	 	 	
            Title: Chief Financial Officer

          
	 	 	
            Address: 12010 Sunset Hills Road, Reston VA 20190

          
	 	 	
            Legal Name: ATAC Services, LLC

          
	 	 	
            Jurisdiction of Formation: Delaware

          

    

    

    	 	
            ARIC SERVICES, LLC

          
	 	 
	 	
            by

          	 
	 	 	/s/ Charles A. Mathis
	 	 	
            Name: Charles A. Mathis

          
	 	 	
            Title: Chief Financial Officer

          
	 	 	
            Address: 12010 Sunset Hills Road, Reston VA 20190

          
	 	 	
            Legal Name: ARIC Services, LLC

          
	 	 	
            Jurisdiction of Formation: Delaware

          

    

    

    	 	
            SUPPORT SERVICES ORGANIZATION, LLC

          
	 	 
	 	
            by

          	 
	 	 	/s/ Charles A. Mathis
	 	 	
            Name: Charles A. Mathis

          
	 	 	
            Title: Chief Financial Officer

          
	 	 	
            Address: 12010 Sunset Hills Road, Reston VA 20190

          
	 	 	
            Legal Name: Support Services Organization, LLC

          
	 	 	
            Jurisdiction of Formation: Delaware

          

    

    

    	 	
            TEXELTEK, LLC

          
	 	 
	 	
            by

          	 
	 	 	/s/ Charles A. Mathis
	 	 	
            Name: Charles A. Mathis

          
	 	 	
            Title: Chief Financial Officer

          
	 	 	
            Address: 12010 Sunset Hills Road, Reston VA 20190

          
	 	 	
            Legal Name: Texeltek, LLC

          
	 	 	
            Jurisdiction of Formation: Delaware

          

    

    

    
      [Signature page to Supplement to Guarantee and Collateral Agreement]

    

    
      
        

    

    	 	
            TASC SERVICES CORPORATION

          
	 	 
	 	
            by

          	 
	 	 	/s/ Charles A. Mathis
	 	 	
            Name: Charles A. Mathis

          
	 	 	
            Title: Chief Financial Officer

          
	 	 	
            Address: 12010 Sunset Hills Road, Reston VA 20190

          
	 	 	
            Legal Name: TASC Services Corporation

          
	 	 	
            Jurisdiction of Formation: Delaware

          

    

    

    
      [Signature page to Supplement to Guarantee and Collateral Agreement]

    

    
      
        

    

    	 	
            CITIBANK, N.A., as Collateral Agent,

          
	 	 
	 	
            by

          	 
	 	 	/s/ Justin Tichauer

          
	 	 	
            Name: Justin Tichauer

          
	 	 	
            Title: Vice President

              

          

    

    

    
      [Signature page to Supplement to Guarantee and Collateral Agreement]

    

    
      
        

    

    EQUITY INTERESTS

    

    

    	
            Issuer

          	
            Number of

            Certificate

          	
            Registered

            Owner

          	
            Number and

            Class of

            Equity Interest

          	
            Percentage

            of Equity Interests

          
	
            Engility Holdings, Inc.

          	
            C-1

          	
            Science Applications International Corporation

          	
            100 Common Shares

          	
            100%

          
	
            Engility Corporation

          	
            6

          	
            Engility Holdings, Inc.

          	
            1,000 Common Shares

          	
            100%

          
	
            Engility LLC

          	
            N/A

          	
            Engility Corporation

          	
            LLC interests

          	
            100%

          
	
            ATAC Services, LLC

          	
            N/A

          	
            Engility LLC

          	
            LLC interests

          	
            100%

          
	
            ARIC Services, LLC

          	
            N/A

          	
            Engility LLC

          	
            LLC interests

          	
            100%

          
	
            Support Services Organization, LLC

          	
            N/A

          	
            Engility Corporation

          	
            LLC interests

          	
            100%

          
	
            Texeltek, LLC

          	
            N/A

          	
            Engility Corporation

          	
            LLC interests

          	
            100%

          
	
            TASC Services Corporation

          	
            2

          	
            Engility Corporation

          	
            1,000 Shares

          	
            100%

          
	
            TM Creditors

          	
            N/A

          	
            Engility LLC

          	 	
            0.075785%

          

    

    

    PLEDGED DEBT SECURITIES

     

      

    	
            Issuer

          	
            Registered

            Creditor

          	
            Principal

            Amount

          	
            Date of Note

          	
            Maturity Date

          
	
            N/A

          	
            N/A

          	
            N/A

          	
            N/A

          	
            N/A

          

    

    

    
      
        

    

    EXISTING CONTRACTS PROHIBITING SUBSIDIARY GUARANTEES

    

    

    1.          Forfeiture Support Associates, LLC

    
      
        

    

    INTELLECTUAL PROPERTY

    

    

    U.S. COPYRIGHTS OWNED BY ENGILITY CORPORATION

    

    

    U.S. Copyright Registrations

    

    

    	
            Owner

          	
            Title

          	
            Reg. No.

          	
            Reg. Date

          
	
            Analytic Sciences Corporation (TASC)

          	
            Internal validation summary statistics

          	
            TXu000534171

          	
            July 6, 1992

          
	
            Analytic Sciences Corporation (TASC)

          	
            LODESTAR cost of service

          	
            Txu000528190

          	
            July 6, 1992

          
	
            Analytic Sciences Corporation (TASC)

          	
            LODESTAR domains ratio

          	
            Txu000528167

          	
            July 8, 1992

          
	
            Analytic Sciences Corporation (TASC)

          	
            LODESTAR graphics

          	
            Txu000527884

          	
            July 6, 1992

          
	
            Analytic Sciences Corporation (TASC)

          	
            Lodestar late cut reporter

          	
            Txu000529502

          	
            July 6, 1992

          
	
            Analytic Sciences Corporation (TASC)

          	
            LODEstar PC/interface

          	
            Txu000533911

          	
            July 2, 1992

          
	
            Analytic Sciences Corporation (TASC)

          	
            Lodestar ratio analysis program

          	
            Txu000547932

          	
            July 2, 1992

          
	
            Analytic Sciences Corporation (TASC)

          	
            Lodestar sampling

          	
            Txu000527097

          	
            July 6, 1992

          
	
            Analytic Sciences Corporation (TASC)

          	
            LODESTAR solid state validation package

          	
            TXu000528191

          	
            July 6, 1992

          
	
            Analytic Sciences Corporation (TASC)

          	
            LODESTAR substation analysis package

          	
            TXu000533985

          	
            July 2, 1992

          
	
            Analytic Sciences Corporation (TASC)

          	
            LODESTAR tool kit

          	
            TXu000528030

          	
            July 2, 1992

          
	
            Analytic Sciences Corporation (TASC)

          	
            LODESTAR totalizing reporter

          	
            TXu000533986

          	
            July 6, 1992

          

    
      
        

    

    	
            Analytic Sciences Corporation (TASC)

          	
            LODESTAR version 5

          	
            TXu000534366

          	
            June 29, 1992

          
	
            Analytic Sciences Corporation (TASC)

          	
            Lodestar: coincident peak analysis program

          	
            TXu000529370

          	
            July 6, 1992

          
	
            Analytic Sciences Corporation (TASC)

          	
            LODESTAR: individual customer analysis

          	
            TXu000527530

          	
            July 6, 1992

          
	
            Analytic Sciences Corporation (TASC)

          	
            TASC AdaGRAPH: source code

          	
            TX0002105965

          	
            June 12, 1987

          
	
            Analytic Sciences Corporation (TASC)

          	
            TASC QNET

          	
            TX0003106842

          	
            June 3, 1991

          
	
            Dynamics Research Corporation

          	
            Cycle interpolation monochip metallization mask work, MLA3454A

          	
            MW0000001798

          	
            July 28, 1986

          
	
            Dynamics Research Corporation

          	
            Data accessor for Digital Equipment Corporation’s VAX computer

          	
            TXu000302267

          	
            October 26, 1987

          
	
            Dynamics Research Corporation

          	
            Data accessor for the Honeywell DPS-8

          	
            Txu000302266

          	
            October 26, 1987

          
	
            Dynamics Research Corporation

          	
            Expense tracking and planning system (ETAPS) reports

          	
            TX0005953722

          	
            April 1, 2004

          
	
            Dynamics Research Corporation

          	
            First ten pages of “Network interface for the I B M PC

          	
            TXu000302553

          	
            October 26, 1987

          
	
            Dynamics Research Corporation

          	
            Network supervisor for Digital Equipment Corporation’s VAX computer

          	
            Txu000302254

          	
            October 26, 1987

          
	
            Tasc, Inc.

          	
            Math assignments grades four through eight: Math drills

          	
            Txu000307085

          	
            December 9, 1987

          
	
            Tasc, Inc.

          	
            Tasc quickview version 1.1

          	
            TXu000726051

          	
            February 26, 1996

          
	
            Tasc, Inc.

          	
            Tasc, Inc. AIDS brief risk intervention (B R I)

          	
            TXu000331894

          	
            July 18, 1988

          

    
      
        

    

    LICENSES

    

    

    I.  Licenses/Sublicenses of New Subsidiaries as Licensor/Sublicensor on Date Hereof

    

    

    None.

    

    

    II.  Licenses/Sublicenses of New Subsidiaries as Licensee/Sublicensee on Date Hereof

    

    

    Sublicense Agreement dated April 26, 2017, as amended May 15, 2018, by and between Emirates Training Technology LLC and Engility Corporation.

    
      
        

    

    PATENTS OWNED BY ENGILITY CORPORATION

    

    

    U.S. Patents

    

    

    	
            Owner

          	
            Title

          	
            Serial No.

            Filing Date

          	
            Patent No.

            Issue Date

          	
            Status

          
	
            Engility Corporation

          	
            APPARATUS AND METHOD FOR PROVIDING PROGRAM PROTECTION ENGINEERING, SECURITY MANAGEMENT, AND REPORT PREPARATION FOR SENSITIVE AND
                CLASSIFIED PROJECTS

          	
            11/347,285

             

            February 6, 2006

          	
            7,865,388

             

            January 4, 2011

          	
            Issued

          

    

    

    

    

    U.S. Patent Applications

     

      

    	
            Owner

          	
            Title

          	
            Serial No.

            Filing Date

          	
            Patent No.

            Issue Date

          	
            Status

          
	
            Engility Corporation

          	
            SYSTEM AND METHOD FOR COMPUTERIZED DATA PROCESSING, ANALYSIS AND DISPLAY

          	
            15/676,982

             

            August 14, 2017

          	
            N/A

          	
            Pending

          

    

    

    PATENTS OWNED BY ENGILITY LLC

    

    

    U.S. Patents

    

    

    	
            Owner

          	
            Title

          	
            Serial No.

            Filing Date

          	
            Patent No.

            Issue Date

          	
            Status

          
	
            Engility LLC

          	
            PRESERVING THE CONTENT OF A COMMUNICATION SIGNAL CORRUPTED BY INTERFERENCE DURING TRANSMISSION

          	
            12/274,636

             

            November 20, 2008

          	
            8,175,186

             

            May 8, 2012

          	
            Issued

          

    
      
        

    

    TRADEMARK/TRADE NAMES OWNED BY ENGILITY CORPORATION

    

    

    U.S. Trademark Registrations

    

    

    	
            Mark

          	
            Serial No.

            Filing Date

          	
            Reg. No.

            Reg. Date

          	
            Status

          	
            Owner of Record

          
	
            
              

              

              
              

              

            

          	
            85207204

             December 29, 2010

          	
             4220167

            October 9, 2012

          	
             Registered

          	
            Engility Corporation

          
	
            

          	
            85206406

            December 28, 2010

          	
            4220166

            October 9, 2012

          	
             Registered

          	
            Engility Corporation

          
	
            

          	
            85197087

            December 14, 2010

          	
            4354368

            June 18, 2013

          	
             Registered

          	
            Engility Corporation

          
	
            TASC (Typed Drawing)

          	
            73223006

            July 12, 1979

          	
            1172637

            October 6, 1981

          	
             Registered

          	
            Engility Corporation

          
	
            

          	
            85975933

            June 17, 2010

          	
             4115094

            March 20, 2012

          	
             Registered

          	
            Engility Corporation

          
	
            

          	
            85084378

             July 14, 2010

          	
             4289442

            February 12, 2013

          	
             Registered

          	
            Engility Corporation

          
	
            

          	
            77969427

            March 26, 2010

          	
             4430401

            November 12, 2013

          	
             Registered

          	
            Engility Corporation

          
	
            DRC (Typed Word Mark)

          	
            72424969

            05/19/72

          	
            0979114

            February 19, 1974

          	
             Registered

          	
            Dynamics Research Corporation

          
	
            

          	
            75611016

            12/22/98

          	
             2754719

            August 26, 2003

          	
             Registered

          	
            Dynamics Research Corporation

          

    
      
        

    

    TRADEMARKS OWNED BY ENGILITY LLC

    

    

    	
            Mark

          	
            Serial No.

            Filing Date

          	
            Reg. No.

            Reg. Date

          	
            Status

          	
            Owner of Record

          
	
            

          	
            75402974

            December 10, 1997

          	
             2266440

            August 3, 1999

          	
             Registered

          	
            Engility, LLC

          
	
            

          	
            85382392

            July 27, 2011

          	
             4236110

            November 6, 2012

          	
             Registered

          	
            Engility LLC

          
	
            

          	
            86165568

            01/14/14

          	
            4635942

            November 11, 2014

          	
             Registered

          	
            Engility LLC

          

    

    

    Trade Names

    

    

    Trade names used by Engility Corporation and its affiliates to identify legal entities, including without limitation “DRC,” “TASC” and
        “MPRI,” as well as trade names used by Engility Corporation and its affiliates associated with products or services, including without limitation “Roma.”Exhibit 10.4

 

Second Supplement to the Employment Agreement of Dr. Yiftach Roth

 

At the General Meeting of Shareholders of Brainsway Ltd. (the “Company”) that took place on April 5, 2011, it was resolved to approve an amendment to the terms of employment of Dr. Yiftach Roth, one of the Company’s directors, as the Company’s R&D manager, so that the employment agreement between Dr. Roth and the Company’s wholly-owned subsidiary, Brain Research and Development Services Ltd., shall be extended indefinitely, with each side being entitled to terminate the agreement upon 180 days prior written. All of the other terms of such employment agreement will remain unmodified.

 

Brainsway Ltd.

Brain Research and Development Services Ltd.

 

	
/s/ Uzi Sofer
    	
 
    	
/s/ Dr. Yiftach Roth
    
	
By: Uzi Sofer, CEO
    	
 
    	
Dr. Yiftach Roth
    

 

 

Supplement to the Employment Agreement of Dr. Yiftach Roth

 

In the General Meeting dated May 25, 2009, it was resolved to approve the amendment in the terms of employment of Mr. Yiftach Roth, one of the Company’s directors and a holder of controlling interest in the Company, as the Company’s R&D manager, so that beginning as of April 2009, Dr. Roth will be entitled to receive a gross monthly salary of NIS 20,000, instead of his current monthly salary in a gross amount of NIS 13,453. All of the other terms of the Employment Agreement between Dr. Roth and the Company will remain unmodified.

 

In addition, it was resolved to approve a bonus payment to Mr. Yiftach Roth, one of the Company’s directors and a holder of controlling interest in the Company, for the year 2008, in a total amount of NIS 100,000 (cost to the Company), due to the Company’s achievements in the product development field, including the coils required for the performance of the Company’s clinical trails.

 

Brain Research and Development Services Ltd.

 

	
/s/ Uzi Sofer
    	
 
    	
/s/ Dr. Yiftach Roth
    
	
By: Uzi Sofer, CEO
    	
 
    	
Dr. Yiftach Roth
    

 

 

First Amendment to the Employment Agreement

 

That was made and signed on May 9, 2006

 

 

Between:                                             Brain Research and Development Services Ltd.

Of 15 HaRechavim Street, Jerusalem

(hereafter: ‘the company’)

 

Of the one part;

 

And between        Dr Yiftach Roth

I.D. 024698631

Address: Rehelim, Efraim

(hereafter: ‘the employee’)

 

Of the other part;

 

Whereas                                                                                              the parties entered into an employment agreement on April 3, 2006 (hereafter: ‘the employment agreement’).

 

And whereas                                                                        the parties wish to change some of the terms of the employment agreement pursuant to what is stated below.

 

Wherefore it has been agreed as follows:

 

1.                                      The employment agreement shall come into effect from the date of the commencement of the employment as determined in the employment agreement and shall remain in force until five years have passed from that date, unless it is cancelled by one of the parties pursuant to clause 1 of the employment agreement.

 

2.                                      The provisions of this amendment override any conflicting provision in the employment agreement.

 

In witness whereof the parties have signed below:

 

	
Brain Research and Development Services Ltd.
    	
 
    	
The employee
    
	
By ( - )
    	
/s/ Uzi Sofer
    	
 
    	
/s/ Yiftach Roth
    
	
Position: CEO
    	
 
    	
 
    
				

 

Brain Research and Development Services Ltd.

Private company 513443788

 

 

Employment Agreement

 

That was made and signed on April 3, 2006

 

Between:                                             Brain Research and Development Services Ltd.

Of 15 HaRechavim Street, Jerusalem

(each of the companies hereafter: ‘the company’)

 

Of the one part;

 

And between        Dr Yiftach Roth

I.D. 024698631

Address: Rehelim, Mobile Post Efraim

(hereafter: ‘the employee’)

 

Of the other part;

 

Whereas                                                                                              the employee have provided the company and/or Brainsway Inc., the company that controls the company (hereafter: ‘the holding company’) services up to the date of the commencement of the employment, as defined below, and in return for these services he received payment from the company, in return for which he produced a tax invoice.

 

And whereas                                                                        the company is interested in continuing to receive services from the employee, and the employee is interested in continuing to provide services to the company, and both of them are interested in regulating the terms for the provision of the services as aforesaid by way of employment by the company, all of which pursuant to the terms and provisions of this employment agreement (‘the agreement’).

 

Wherefore it is agreed as follows:

 

1.                                      The employment

 

1.1                               The employee’s employment shall begin on May 1, 2006 (‘the date of commencement of the employment’). The employee shall be employed on a part time basis of forty hours a week. The employee shall be employed in the capacity of a physicist or in any other capacity on a similar standard, as shall be required by the company. The employee undertakes to carry out his undertakings and duties that will be imposed on him by the company from time to time. The employee shall be subordinate to the CEO, who shall act as the direct supervisor of the employee.

 

1.2                               The work shall be performed on Sundays to Thursdays, during the work hours defined in the law. The weekly rest day of the employee shall be Saturday.

 

 

1.3                               The employee hereby agrees that the company has a right, at its sole and absolute discretion, to reduce the scope of the employee’s employment, and consequently also the consideration that is payable for it pursuant to this agreement proportionately. The employee hereby waives any claim of a significant worsening of the work conditions as a result of a reduction in the scope of employment by the company as stated in this clause.

 

1.4                               The employee undertakes to devote all of his time, attention, ability and energy exclusively to carrying out his duties in the company, and he undertakes not to enter into an agreement, whether as an employee or in another way, with any business, commercial and/or professional activity, whether for payment or not, during the period of his employment, including after the hours of the work, at weekends and/or during any vacation period, without the prior written consent of the company. In order to remove doubt, it is hereby clarified that the provisions of this clause shall not derogate from the undertakings of the employee as described in appendix B that is attached hereto.

 

1.5                               Each of the parties shall be entitled to cancel this agreement at any time by giving thirty (30) days’ notice in writing (hereafter — ‘the notice period’).

 

1.6                               Notwithstanding the aforesaid, the company shall be entitled to terminate the employee’s employment immediately or to shorten the duration of the notice period, whether it is given by the company or it is given by the employee, provided that in such a case the employee shall be entitled to compensation in an amount equal to his basic salary as stated in appendix A, as if he were employed by the company until the end of the notice period as stated in clause 1.4 above.

 

1.7                               Should the employee resign without complying with the duty of giving notice, the employer may deduct from any amount payable to the employee, as pre-agreed compensation, an amount equal to the ordinary salary that the employee would have received for the notice period during which he did not work. This shall not derogate from the company’s right, instead of the agreement compensation, to sue the employee for the damage that it suffered de facto as a result of the employee not carrying out his obligation to give notice.

 

1.8                               Notwithstanding the aforesaid, and without derogating from its rights pursuant to this agreement, the company shall be entitled to terminate the employee’s employment without any need for giving notice and without derogating from any relief to which the company is entitled pursuant to any law and/or agreement, if one or more of the following incidents occurs: (1) the employee embezzled the company’s money; or (2) the employee committed a fundamental breach of this agreement; or (3) the employee committed or was involved in an act, deed or omission, which constitutes a breach of faith to the company; or (4) the employee committed a disciplinary infraction; or (5) the employee’s conduct caused serious damage to the company; or (6) the employee was convicted of a criminal offence; or (7) the employee is not capable of carrying out his duties in the company for a period exceeding ninety (90) continuous days. Returning to work for periods that are shorter than fifteen (15) continuous days shall not interrupt the period of the aforesaid ninety (90) days.

 

2

 

1.9                               The employee shall not have a right of lien on the company’s assets, equipment or any other material, including information and confidential information as defined in appendix B of this agreement (hereafter: ‘the company’s equipment’) that is in his possession. The employee shall return to the company all of the company’s equipment that is in his possession no later than the date on which the employment relationship is terminated and also when he goes on holiday for more than 30 days (including paternity leave, or leave in lieu of notice), before going on such leave, or within seven days of the date on which he receives a demand from the company to do so.

 

2.                                      Consideration

 

As consideration for his employment in the company and for complying with the provisions of this agreement, and subject to what is stated in this agreement, including what is stated in its appendices, the employee shall be entitled to salary, terms and benefits as set out in appendix A that is attached hereto.

 

3.                                      Confidentiality, non-competition and ownership of inventions

 

At the same time as he signs this agreement, the employee shall sign an undertaking to the company with regard to confidentiality, non-competition and rights in inventions in favor of the company and any subsidiary or holding company of the company, which is attached hereto as appendix B.

 

4.                                      Representations and undertakings

 

The employee declares and undertakes as follows:

 

4.1                               That he does not have, nor did he have in the past, any claim against the company for providing services to the company before the date of the commencement of the employment and that he makes an informed and irrevocable waiver of any contention and/or claim against the company based on his employment with the company and/or providing services to the company prior to the date of this agreement.

 

4.2                               That he is not bound by undertakings or any other agreements whatsoever that prevent him from making an undertaking in accordance with the provisions of this agreement and from acting in accordance herewith.

 

4.3                               That to the best of his knowledge he is not in breach of any rights and/or undertakings to his former employer.

 

3

 

4.4                               That he has the ability, the skills and the knowledge that are required for the purpose of carrying out the job in accordance with the provisions of this agreement.

 

4.5                               That he will notify the company, immediately and without delay, of any matter or issue in which he and/or his close family have and/or may have a personal interest and/or with regard to which there may be a conflict of interests with his duties and work for the company.

 

4.6                               That he shall not receive any payment and/or other benefit from any third party directly or indirectly with regard to his work in the company. If the employee breaches this clause, then without derogating from the rights of the company pursuant to any agreement or pursuant to law, the amount and/or benefit as aforesaid shall be the property of the company and shall be transferred to it, and the company shall also be entitled to deduct that amount or the value of the benefit from any amount due to the employee from it.

 

4.7                               That within the framework of carrying out his job in the company he shall not act and/or shall not make any representation and/or shall not give any undertaking on behalf of the company and/or shall not take upon himself any undertaking and/or shall not give any guarantee on behalf of the company unless he has prior, written and express instructions from the company and/or its directors and/or his superiors.

 

4.8                               That he agrees and confirms that from time to time he may be required to travel and stay abroad within the framework of his job.

 

4.9                               That in exceptional cases in which there will be a need for this, pursuant to a decision of the company management, the employee will participate in a lie detector (polygraph) test.

 

4.10                        That he undertakes to make use of the company’s equipment and its resources solely for the purpose of carrying out his work and within the framework of his job and that he knows and agrees that the company may make checks on the premises of the company’s offices and in the company’s computers, including e-mail messages and the manner of using the Internet, and the content of all of the aforesaid. In order to remove doubt, it is hereby clarified that the results of the test will be the sole property of the company.

 

4.11                        That in any case of a cancellation of this agreement for any reason, the employee will cooperate with the company and do his best to assist in an orderly transfer of his job in the company and an orderly transition between him and the person designated to replace him in the job.

 

4

 

5.                                      General provisions

 

5.1                               This agreement and all of its appendices that are attached hereto constitute the full agreement between the parties hereto and they override any agreements, proposals, understandings and previous arrangements, whether oral or in writing, if any of these were actually made between the parties with regard to the subject of this agreement.

 

5.2                               Any change and/or addition to this agreement shall bind the parties to the agreement and shall be valid vis-à-vis the parties only if they are in writing and are signed by the parties.

 

5.3                               This agreement shall be governed by Israeli law and shall be interpreted in accordance therewith. The Tel-Aviv Regional Labor Court shall have sole and exclusive jurisdiction with regard to any matter arising from this agreement or relating to this agreement.

 

5.4                               The invalidity and/or cancellation and/or voiding of any of the provisions of this agreement and its appendices shall not derogate from the full validity of any other provisions of the agreement and its appendices.

 

5.5                               The employee confirms and declares that he has thoroughly read and understood all of the provisions of the agreement and its appendices, that these provisions are acceptable to him without reservation and that he is signing the agreement and its appendices freely and voluntarily.

 

5.6                               Any notice should be sent by one party to the other at the address of the party that is stipulated in the preamble to this agreement or any other address of which a party gives notice pursuant to the provisions of this agreement, by registered mail or by hand, and any notice that is sent by registered mail shall be deemed to have been received by the addressee four business days after it is delivered to the post office, and if it is delivered by hand, at the time of delivery, provided that confirmation of delivery is obtained.

 

In witness whereof the parties have signed below:

 

	
Brain Research and Development   Services Ltd.
    	
 
    	
The employee
    
	
By: 
    	
/s/ Uzi Sofer
    	
 
    	
/s/ Yiftach Roth
    
	
Position: CEO
    	
 
    	
 
    
				

 

Brain Research and Development Services Ltd.

Private company 513443788

 

5

 

Appendix A — Consideration

 

1.Salary

 

For his full time work for the company, the employee shall be entitled to a gross monthly salary in an amount of NIS 13,453 (‘the basic salary’).

 

The employee’s basic salary includes a salary component as a payment for his work in normal hours that is equal to 80% of the basic salary and a payment of a work component for overtime which is estimated and equal to 20% of the basic salary. In order to remove doubt, this is not an additional salary component but the basic salary includes the two aforesaid components and constitutes the amount of the consideration to which the employee is entitled pursuant to the Work and Rest Hours Law, 5711-1951.

 

The company will assess the employee’s performance and the company’s performance once a year and it will decide at its sole discretion whether to increase the employee’s basic salary, and if so, by what percentage or amount.

 

2.                                      Insurance policies

 

Subject to the guidelines that will be determined from time to time by the Income Tax Commission, and pursuant to the maximum amount deductible, the company will insure the employee in a ‘managers’ insurance policy’ (hereafter: ‘managers’ insurance’) and will make the following provisions: (1) the company will pay an amount equal to 5% of the employee’s basic salary into a managers’ insurance policy for the employee (hereafter in this clause — ‘the company’s share’), and it shall deduct 5% of the employee’s basic salary (hereafter in this clause — ‘the employee’s share’) and it shall pay this amount in favor of the managers’ insurance policy for the employee (the division of the components of the managers’ insurance into savings and risk shall be determined at the discretion of the employee); and (2) the company shall pay a sum equal to 81/3% of the employee’s basic salary into a severance pay fund.

 

The employee hereby instructs the company to transfer to the managers’ insurance policy the amounts that constitute the employee’s and the employer’s shares out of each payment of monthly salary. To remove doubt, if the employee accumulates an aggregate amount in the fund that exceeds the maximum amount stipulated in an Income Tax Order, the surplus amount shall be regarded as income for tax purposes.

 

3.                                      Release of funds

 

3.1                               Without derogating from the company’s right under any law and/or this agreement, the managers’ insurance policy shall be transferred to the employee, subject to the applicable law and subject to the performance of all of the employee’s undertakings to the company when the employee’s employment is terminated for any reason, excluding in circumstances where the employment is terminated as stated in clause 1.7 of the agreement.

 

6

 

3.2                               It is hereby clarified that pursuant to section 14 of the Severance Pay Law, 5723-1963 (hereafter in this clause — ‘the law’) and the general approval regarding employers’ payments to a pension fund and an insurance fund in lieu of severance pay, which is attached to this agreement (hereafter — ‘the approval’), the amount that will be accumulated for the employee in the insurance policy during his employment for the company until the date on which his employment with it is terminated shall replace severance pay.

 

Pursuant to the terms of the approval, the employer hereby waives any right that he may have to a reimbursement of the money from his payments, unless the employee’s right to severance pay is denied subject to the circumstances described in this agreement and sections 16 and 17 of the law, to the extent that it is denied or the employee withdraws money from the pension fund or from the insurance fund without there being a qualifying event; for this purpose, ‘qualifying event’ — death, disability or retirement at the age of sixty or more.

 

4.                                      Vacation, sick pay and holiday pay

 

Subject to the provisions of the Annual Vacation Law, 5711-1951 (‘the Annual Vacation Law’), the employee shall be entitled to a twelve (12) work day vacation for each twelve (12) month period of his employment, and provided that such vacation may be credited to the employee only for the following two years. If the employee does not use the number of vacation days to which he is entitled during a work year, the employee shall be entitled to redeem the vacation days that he did not use pursuant to the provisions of the Annual Vacation Law. It is clarified that the vacation dates shall be determined by the company by arrangement with the employee.

 

The employee shall be entitled to payment of sick pay and holiday pay according to law.

 

The dates of leaving for vacation shall be determined by the company in accordance with its possibilities and needs, and when it is possible, while taking into account the employee’s wishes. The company shall be entitled to introduce a standard annual vacation for all or some of its employees, with regard to some or all of the vacation entitlement, as it shall see fit.

 

5.                                      Options

 

Subject to the resolutions of the board of directors of the company (hereafter: ‘the board of directors’) and/or the company’s options and bonuses committee, at its sole discretion, and subject to the terms of the options plan and the agreement to grant options that were approved and/or will be approved for this purpose from time to time by the board of directors at its sole discretion, which will include the terms regarding the options, including the exercise date and price, the blocking and unblocking thereof, and all the other conditions and terms regarding the options, the employee shall be entitled to 40,000 options to receive 40,000 ordinary shares of the company with a value of US $ 0.01 each (hereafter: ‘the options’).

 

7

 

Any tax liability with regard to the options (including with regard to the grant, exercise, sale of the options or the shares that are received when they are exercised) shall be payable solely by the employee.

 

6.                                      Business expenses

 

The company shall reimburse the employee for accepted and required business expenses that the employee shall actually incur on behalf of the company and in its stead, pursuant to the company policy as shall be determined by the company from time to time.

 

7.                                      Taxes

 

The company shall deduct at source or debit the employee for taxes and/or other compulsory payments as required by law with regard to or deriving from the consideration payable to the employee and/or received by him with regard to all of the bonuses to which the employee is entitled or may be entitled.

 

Brain Research and Development Services Ltd.

Private co. 513443788

 

8

 

Appendix B — Letter of undertaking

 

Whereas Brain Research and Development Services Ltd. (hereafter: Brain Research and Development Services Ltd. and each of its subsidiaries, holding companies and affiliates — ‘the company’) is interested in employing the employee, subject to making this undertaking (hereafter: ‘the undertaking’);

 

And whereas Dr. Yiftach Roth, holder of ID no. 024698631, of Rehelim Street, [city] Mobile Post Efraim (hereafter — ‘the employee’), is interested in entering into the aforesaid terms of employment;

 

Wherefore, the employee declares and undertakes to the company as follows:

 

1.Confidential information

 

The employee recognizes that he will have access to confidential information and to information concerning the activities of the company and technologies relating to the company, research and development of products, patents, copyrights, commercial secrets, customers (including customer lists), marketing plans, strategies, forecasts, commercial secrets, results of tests, examinations and experiments, formulae, processes, information, knowledge, improvements, inventions, techniques and products (existing or planned). Such information in any form whatsoever, whether in a document, letter, orally, on a computer or on magnetic media shall be regarded as ‘confidential information.’

 

The employee shall not disclose during the period of his employment with the company or at any time after the end of the period of his employment, for any reason, to any person, corporation, partnership or other entity, any confidential information whether orally, in writing or in any other way, that came into the possession of the employee or was brought to his attention during the period of his employment with the company (including the processes and the technologies that are being used or that will be used by the company in its business, the methods and results of the company’s research, technical or financial information, the employee’s terms of employment and those of the other employees of the company or any other information regarding the company’s business or any information with regard to the company’s customers), unless he receives the prior written consent of the company.

 

2.                                      Confidential information shall be regarded as including all confidential information that was delivered by, for or on behalf of the company, irrespective of its form, except for information that the employee can prove entered the public domain other than as a result of a breach of this undertaking by the employee.

 

3.                                      The employee agrees that all of the memoranda, books, records, lists (which are included on any type of media or in any form), records, formulae, specifications, lists and any other document that was prepared, assembled, processed, received, held or used by the employee during his employment with the company, with regard to any stage of the company’s business or its commercial secrets (hereafter: ‘the materials’), shall be the sole property of the company and shall be transferred by the employee to the company when the period of his employment is terminated or at any time previously or otherwise at the company’s demand, without the employee keeping any copies of the aforesaid and without the employee having a right of lien over them.

 

9

 

4.                                      Unfair competition and prohibited inducement

 

The employee agrees that the terms of this undertaking are reasonable and necessary for the lawful protection of the company’s confidential information, its property (including intellectual property) and reputation (‘the company’s main assets’). The employee declares that he has carefully read the provisions of this undertaking, that he understands the results of this undertaking and agrees to what is stated herein, and that he has assessed for himself the advantages and disadvantages involved in entering into this undertaking. Therefore, the employee undertakes:

 

That during his employment with the company and for a period of twelve months thereafter, he shall not enter into a contract, set up, open or be involved in any way, directly or indirectly, whether as an employee, owner, partner, agent, shareholder, director, adviser or in any other way, in any business, occupation, work or any other activity that may reasonably include or be related to the use of the company’s main assets (as defined above).

 

That during the period of his employment with the company and for a period of twelve months thereafter, he shall not induce any employee of the company or any of its subsidiaries, its holding companies or its affiliates to terminate his employment with them.

 

5.                                      Ownership of inventions

 

The employee shall notify and deliver to the company, or to anyone appointed on its behalf, any information, improvements, inventions, formulae, processes, techniques, knowledge and information, whether it can be registered as a patent or not, which was done or thought up or put into practice or learned by the employee, whether on his own or jointly with others, during the employee’s employment with the company (including after work hours, at weekends or during a vacation) (all such information, improvements, inventions, formulae, processes, techniques, knowledge and information shall be defined hereafter as: ‘inventions’ or ‘the invention’), immediately after discovering them, receiving them or inventing them, as applicable. If the employee is unable for any reason whatsoever to deliver the invention on the date of giving the notice of the invention, the employee shall notify the company of the invention and give details in his notice of the date on which it will be delivered to the employer and the reason for not delivering the invention immediately, and subsequently, as soon as possible, the invention itself shall be delivered.

 

Giving the notice and delivering the inventions shall be done in writing, together with a detailed description of the invention and suitable documentation. The employee agrees that all of the inventions shall be the sole property of the company and its transferees and that the company and its transferees shall be the sole owners of all the patents and other rights relating to such inventions. The employee hereby assigns to the company all of his existing and future rights in such inventions. In order to remove doubt, it is hereby clarified that the lack of a negative answer from the company with regard to notice of an invention or of its delivery shall not be interpreted as a waiver of the ownership of an invention, and in any case the invention shall become the property of the company only.

 

10

 

The employee agrees with regard to all the inventions mentioned above to assist the company, or any person appointed on its behalf, in any appropriate manner, to receive and from time to time to carry out any act, including the implementation and registration of the inventions in any way, including by way of registration of patents for inventions as aforesaid in any country whatsoever, and to sign all of the documents that are required for filing and obtaining a patent for the inventions as aforesaid and for their implementation, as the company shall wish, including letters of assignment for the inventions as aforesaid to the company or persons or entities appointed by it.

 

The employee shall not be entitled, insofar as the aforesaid is concerned, to any pecuniary or other consideration in addition to what is stated in appendix A of this agreement or in addition to what is stated in any other special agreement or arrangement on this matter that are made in writing and signed by the company. Insofar as the aforesaid is concerned, no arrangement, communication or consent that is made orally or in writing shall have any effect, unless they are duly signed by the company.

 

6.General

 

The employee agrees that the provisions of this undertaking, which constitute an integral part of the terms of his employment, are reasonable and necessary in order to protect legitimate interests of the company with regard to the subject of this undertaking.

 

If any court of law determines that any provisions in this undertaking (including any sentence, paragraph or part hereof) is not valid or is unenforceable, then such provisions shall be regarded as if they were amended in such a way that the parts that were determined as aforesaid to be not valid or unenforceable will be struck out. The striking out as aforesaid shall apply only with regard to duties and requirements mentioned in the provision as aforesaid in the jurisdiction where the decision as aforesaid is given. Moreover, if it is determined that a certain provision that is included in this undertaking is too broad with regard to the periods of time mentioned therein, the geographic scope, an activity or issue, it shall be interpreted so that the aforesaid provision shall be limited and restricted with regard to the aforesaid characteristic so that the provision shall be enforceable to the greatest degree possible in accordance with the law applicable at that time.

 

The provisions of this undertaking shall remain fully valid even after the termination of the employment period between the company and the employee for any reason whatsoever. This undertaking shall not be used in any way to derogate from the employee’s undertakings and liability under any law.

 

	
 
    	
Signature:
    	
 /s/ Yiftach Roth
    

 

11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}]]